We are live on ! Find out more
PALI icon

Palisade Bio
PALI

96 hedge funds and large institutions have $262M invested in Palisade Bio in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

20% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 25

12% more funds holding

Funds holding: 86 → 96 (+10)

1.07% less ownership

Funds ownership: 91.19% → 90.12% (-1.1%)

18% less capital invested

Capital invested by funds: $319M → $262M (-$57.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
96
Holders Change
+10
Holders Change %
+11.63%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
31
Increased
30
Reduced
25
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BGI
B Group Inc
Texas
+$12.6M
2
Goldman Sachs
Goldman Sachs
New York
+$8.76M
3
Ameriprise
Ameriprise
Minnesota
+$8.36M
4
GPP
Great Point Partners
Connecticut
+$6.19M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$5.7M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$18.3M
2
SC
Stempoint Capital
New York
-$9.85M
3
CC
Commodore Capital
New York
-$7.75M
4
PA
Perceptive Advisors
New York
-$5.68M
5
VC
Vivo Capital
California
-$5.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$20.1M +$8.36M +4,599,083 +67%
BGI
2
B Group Inc
Texas
$20M +$12.6M +6,914,285 +154%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$18.8M +$271K +149,118 +1%
OCA
4
Octagon Capital Advisors
New York
$18M +$1.29M +708,419 +7%
PA
5
Perceptive Advisors
New York
$15.6M -$5.68M -3,121,851 -26%
CC
6
Commodore Capital
New York
$12.6M -$7.75M -4,263,938 -37%
RCM
7
RA Capital Management
Massachusetts
$12.5M – – –
Franklin Resources
8
Franklin Resources
California
$10.1M +$1.26M +692,627 +14%
Goldman Sachs
9
Goldman Sachs
New York
$9.4M +$8.76M +4,816,386 +864%
EP
10
Eversept Partners
New York
$8.73M -$735K -404,049 -7%
BCM
11
Boxer Capital Management
California
$8.4M – – –
Morgan Stanley
12
Morgan Stanley
New York
$7.97M +$744K +409,087 +10%
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$7.88M – – –
GPP
14
Great Point Partners
Connecticut
$5.96M +$6.19M +3,405,757 New
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
$5.72M +$5.36M +2,945,478 +905%
Federated Hermes
16
Federated Hermes
Pennsylvania
$5.49M +$5.7M +3,136,607 New
SCM
17
Squadron Capital Management
Illinois
$5.25M -$2.73M -1,500,000 -33%
Wellington Management Group
18
Wellington Management Group
Massachusetts
$5.08M +$5.28M +2,904,911 New
Marshall Wace
19
Marshall Wace
United Kingdom
$4.82M +$5.01M +2,754,403 New
VPC
20
Vestal Point Capital
New York
$4.38M +$4.55M +2,500,000 New
O
21
OrbiMed
New York
$4.08M +$839K +461,580 +25%
ACM
22
ADAR1 Capital Management
Texas
$3.96M +$473K +260,000 +13%
Millennium Management
23
Millennium Management
New York
$3.68M +$3.29M +1,808,867 +614%
HS
24
HighVista Strategies
Massachusetts
$3.53M +$1.31M +719,295 +55%
AGP
25
Artia Global Partners
Florida
$3.49M – – –
1
2 3 4 5

PALI Hedge Fund Activity: Q1 2026 in Review

96 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2026, worth a combined $262M — down 18% from $319M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PALI positions and 20 closed out — a net gain of 11 holders — while 30 added to existing stakes and 25 trimmed.

The largest buyer was B Group Inc, adding an estimated $12.6M. The largest seller was Point72 Asset Management, cutting an estimated $18.3M.

  • 96 institutional investors held Palisade Bio (PALI) as of Q1 2026, up from 86 in Q4 2025.
  • Funds reported $262M of Palisade Bio stock for Q1 2026, down 18% quarter-over-quarter.
  • 31 funds opened new Palisade Bio positions in Q1 2026 and 20 closed out, a net change of +11 holders.
  • The largest Palisade Bio buyer in Q1 2026 was B Group Inc, an estimated $12.6M added.
  • The largest Palisade Bio seller in Q1 2026 was Point72 Asset Management, an estimated $18.3M sold.

Based on aggregated 13F filings for Q1 2026.